Transcript-Savvy Discovery Is a Smart Bet
Drug Developers Are Finding Ways to Bend the Transcriptome to Their Will
Humanizing Animals for Immuno-Oncology
Success in Humanizing Mice Has Inspired Similar Efforts in Rats, Pigs, and Other Animals
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
Molecular Dx Has Your (Copy) Number
CNV Detection and Analysis Tools Are Being Used To Fill Genetic Diagnostic Gaps
For full access to this article login to GEN Select now.
Opinion: Reining In New Therapeutic Hype Is Critical
Finding the Middle Ground Between Biotech Executive Optimism and Practitioner Pessimism
- In the April 2008 issue of BioExecutive International , Hagen et al., noted that “in presentations by biotech executive investors, seldom is presented a discouraging word.” In the article, the authors encouraged these executives to translate their enthusiasm into language the investment community (which would include larger pharmaceutical licensing ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.